Sarepta Therapeutics’ stock falls after patient dies of liver failure

9 hours ago 2
ARTICLE AD BOX
The company said that more than 800 people have been treated with Elevidys, with only one experiencing liver failure.
Read Entire Article
  1. Homepage
  2. Finance
  3. Sarepta Therapeutics’ stock falls after patient dies of liver failure

Related

Nvidia’s stock falls after GTC. Here’s why Wall Street wasn’t so impressed.

Nvidia’s stock falls after GTC. Here’s why Wall Street wasn’...

15 minutes ago 0
Rescue of stranded astronauts is a win for Musk. This fund offers a ride on the SpaceX roller coaster.

Rescue of stranded astronauts is a win for Musk. This fund o...

16 minutes ago 0
Natural gas may be first to offer a hint when Russia-Ukraine peace deal is near

Natural gas may be first to offer a hint when Russia-Ukraine...

31 minutes ago 0

Trending

1. astros
2. celtics injury report
3. red wings vs capitals
4. notre dame
5. nba starting lineups
6. gulf of america
7. flames vs rangers
8. islanders vs penguins
9. saint francis university
10. nets vs celtics

Popular

Netflix scuttles plans to add six previously announced games to its service

Netflix scuttles plans to add six previously announced games...

1 month ago 126
Steam will label early access games that haven't been updated in a year

Steam will label early access games that haven't been update...

1 month ago 92
OpenAI co-founder John Schulman has left Anthropic after less than a year

OpenAI co-founder John Schulman has left Anthropic after les...

1 month ago 87
Google's Magic Editor will watermark its AI-tweaked photos

Google's Magic Editor will watermark its AI-tweaked photos

1 month ago 84
Metal Gear Solid Delta: Snake Eater release date leaks on the PlayStation Store

Metal Gear Solid Delta: Snake Eater release date leaks on th...

1 month ago 81
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Nexa News 2025. All rights are reserved